tiprankstipranks
Trending News
More News >
Oncolys BioPharma, Inc. (JP:4588)
:4588
Japanese Market
Advertisement

Oncolys BioPharma, Inc. (4588) Income Statement

Compare
0 Followers

Oncolys BioPharma, Inc. Income Statement

Last quarter (Q4 2024), Oncolys BioPharma, Inc.'s total revenue was ¥0.00, a decrease of ― from the same quarter last year. In Q4, Oncolys BioPharma, Inc.'s net income was ¥-438.09M. See Oncolys BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 31.38M¥ 63.04M¥ 976.18M¥ 642.49M¥ 314.18M
Gross Profit
¥ 31.38M¥ 30.61M¥ 338.49M¥ 198.80M¥ 236.11M
Operating Expenses
¥ 1.71B¥ 1.96B¥ 1.54B¥ 1.65B¥ 1.91B
Depreciation and Amortization
¥ 815.00K¥ 2.29M¥ 914.00K¥ 6.49M¥ 4.89M
EBITDA
¥ -1.68B¥ -1.93B¥ -1.14B¥ -1.60B¥ -2.08B
Operating Income
¥ -1.68B¥ -1.93B¥ -1.20B¥ -1.45B¥ -1.67B
Other Income/Expenses
¥ 388.00K¥ -5.59M¥ 58.50M¥ -157.16M¥ -416.71M
Pretax Income
¥ -1.68B¥ -1.94B¥ -1.15B¥ -1.61B¥ -2.09B
Net Income
¥ -1.68B¥ -1.94B¥ -1.15B¥ -1.62B¥ -2.10B
Per Share Metrics
Basic EPS
¥ -77.17¥ -108.92¥ -66.31¥ -95.50¥ -145.58
Diluted EPS
¥ -77.17¥ -108.92¥ -66.31¥ -95.50¥ -145.58
Weighted Average Shares Outstanding
21.83M 17.80M 17.33M 16.92M 14.39M
Weighted Average Shares Outstanding (Diluted)
21.83M 17.80M 17.33M 16.92M 14.39M
Currency in JPY

Oncolys BioPharma, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis